or Try an Advanced Search...

    Related Disease Stocks List

    Symbol Grade Name % Change
    IMRN B Immuron Limited 8.64
    NBIX C Neurocrine Biosciences, Inc. -1.28
    GLMD C Galmed Pharmaceuticals Ltd. -0.23
    REGN D Regeneron Pharmaceuticals, Inc. -0.84
    ERNA D Eterna Therapeutics Inc. 3.12
    IVA F Inventiva S.A. 2.85
    NXTC F NextCure, Inc. 4.65
    GLTO F Galecto, Inc. 5.37
    View As Page of Charts
    Related Industries: Biotechnology Broadcasting - TV
    Related Stock Lists: Cancer Alcohol Clinical Development Clinical Medicine Immunotherapy Medicine Biology Biopharmaceutical Biotechnology Breakthrough Therapy Cardiovascular Disease Diabetes Disorders Fibrosis Immune Related Diseases Immunology Inflammation Medical Research Non Alcoholic Fatty Liver Disease Pain

    Related ETFs - A few ETFs which own one or more of the above listed Related Disease stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 10.54
    BBH D Market Vectors Biotech ETF 10.47
    IBBQ D Invesco Nasdaq Biotechnology ETF 9.65
    IBB D iShares Nasdaq Biotechnology Index Fund 9.46
    MNTL F Tema Neuroscience and Mental Health ETF 8.7
    View all Related Disease ETFs...
    Compare ETFs
    Compare BBH to MNTL Compare IBB to MNTL Compare IBBQ to MNTL

        Related Disease Stocks Recent News

        Date Stock Title
        Apr 25 NBIX Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data
        Apr 25 REGN AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
        Apr 25 REGN Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
        Apr 25 REGN Regeneron (REGN) Reports Next Week: What You Should Expect
        Apr 25 REGN UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
        Apr 25 REGN The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power
        Apr 25 REGN Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
        Apr 25 REGN Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
        Apr 25 REGN Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
        Apr 25 REGN Regeneron expands in gene editing with Mammoth deal
        Apr 24 NBIX Neurocrine launches CAH community website ahead of FDA filing
        Apr 24 NXTC NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
        Apr 24 REGN Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
        Apr 24 NBIX Neurocrine Biosciences upgraded at Wells Fargo on pipeline
        Apr 24 REGN Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
        Apr 24 NBIX Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth
        Apr 24 NBIX Neurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia Community
        Apr 23 NBIX Neurocrine succeeds in mid-stage trial for Takeda-partnered depression drug
        Apr 23 NBIX No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win
        Apr 23 NBIX Neurocrine scores surprise win with depression drug
        Related Industries: Biotechnology Broadcasting - TV
        Related Stock Lists: Cancer Alcohol Clinical Development Clinical Medicine Immunotherapy Medicine Biology Biopharmaceutical Biotechnology Breakthrough Therapy Cardiovascular Disease Diabetes Disorders Fibrosis Immune Related Diseases Immunology Inflammation Medical Research Non Alcoholic Fatty Liver Disease Pain
        Related Disease

        Browse All Tags